Fri Jul 25 19:18:05 SGT 2014  
HEPATITIS
B
    Hepatitis B, Philippines
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Hepatitis B, Philippines

Summary

Hepatitis B, Philippines @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Philippines - Private and confidential service.

Keywords: Hepatitis B Philippines, Philippines Hepatitis B, Hepatitis B.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Philippines
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference


Latest News

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG‐interferon
Thu, 24 Jul 2014 15:41:54 +0100 | Journal of Viral Hepatitis
We examined the role of rs4646536 CYP27B1 SNP (CYP27B1+2838) according to virological and serological response. Our results showed that the TT genotype of CYP27B1+2838 was significantly prevalent in patients with end‐of‐therapy virological response (37.6%) vs CT/CC (9.4%) (P < 0.001). Virological relapse was prevalent in patients with CT/CC genotype (12.6%) vs TT genotype (2.1%) (P < 0.001). TT genotype was also related to HBsAg loss (P = 0.004) and anti‐HBs appearance (P = 0.002). In the multivariate analysis, the TT genotype resulted to be a good positive predictor of sustained virological response (OR = 5.632, IC = 1.938–16.368, P = 0.001) and serological response (OR = 6.161, IC = 1.856–20.457, P = 0.003). The CYP27B1+2838 polymorphism may be useful ...

Response to post-donation counseling is still a challenge in outdoor voluntary blood donation camps: A survey from a tertiary care regional blood center in Eastern India
Thu, 24 Jul 2014 00:00:00 +0100 | Asian Journal of Transfusion Science
Conclusion: The response to the post-donation counseling appears in this study to be only 34% (47/138), which is still a challenge. (Source: Asian Journal of Transfusion Science)

Treponema pallidum hemagglutination assay seroreactivity among healthy Indian donors and its association with other transfusion transmitted diseases
Thu, 24 Jul 2014 00:00:00 +0100 | Asian Journal of Transfusion Science
Discussion: In our study, the TPHA seropositivity correlated with higher HIV and HCV seropositivity and the same correlation has been observed by several other studies also. In view of these observations, we propose that testing for syphilis by more sensitive and specific treponemal markers like TPHA rather than VDRL, rapid plasma reagin tests; as TPHA also has the added advantage of picking up all the high risk donors, whereas, VDRL picks up only currently infected donors. Moreover, TPHA should be continued as a marker of high risk behavior especially in high prevalence areas like India where we don't have universal access to markers like nucleic acid amplification technique. (Source: Asian Journal of Transfusion Science)

Targeted testing in primary care demonstrates high prevalence of hepatitis B infection within the Slovak–Roma population in Sheffield, UK
Thu, 24 Jul 2014 00:00:00 +0100 | Journal of Viral Hepatitis
(Source: Journal of Viral Hepatitis)

WHO welcomes global momentum on viral hepatitis
Wed, 23 Jul 2014 09:00:00 +0100 | WHO news
On World Hepatitis Day, 28 July, WHO welcomes new progress in tackling one of the world’s most serious diseases. Viral hepatitis – a group of infectious diseases known as hepatitis A, B, C, D, and E – affects millions of people worldwide, causing acute and chronic liver disease and killing close to 1.4 million people every year. “For years, viral hepatitis has been largely neglected,” says Dr Margaret Chan, Director-General at WHO. “But now we are beginning to see greater awareness and global momentum building to tackle it.” (Source: WHO news)

Entecavir Does Not Eliminate HCC Risk in Hepatitis B PatientsEntecavir Does Not Eliminate HCC Risk in Hepatitis B Patients
Wed, 23 Jul 2014 02:15:58 +0100 | Medscape Gastroenterology Headlines
Patients taking entecavir for chronic hepatitis B are still at risk for hepatocellular carcinoma (HCC), a recent study suggests. Reuters Health Information (Source: Medscape Gastroenterology Headlines)

The use of ustekinumab in a patient with severe psoriasis and positive HBV serology
Wed, 23 Jul 2014 02:12:40 +0100 | Anais Brasileiros de Dermatologia
We report the case of a patient with severe psoriasis with positive serology for the Hepatitis B virus, who received ustekinumab (a human monoclonal antibody against interleukin 12 and 23). In this patient, the use of ustekinumab did not reactivate the Hepatitis B virus. Given the high prevalence of chronic viral infections in patients who are candidates for biologic therapy, as well as the potential for reactivate chronic viral illness, randomized controlled studies are needed to assess the risks and benefits of such therapy in these populations. (Source: Anais Brasileiros de Dermatologia)

Screening and confirmatory testing strategies for the major transfusion‐transmissible viral infections
Wed, 23 Jul 2014 00:00:00 +0100 | ISBT Science Series
ConclusionsEven in resource constrained settings optimally designed screening and confirmatory strategies can significantly reduce the risk of transfusion‐transmissible viral infection. (Source: ISBT Science Series)

Infectivity of HBV and screening strategy
Wed, 23 Jul 2014 00:00:00 +0100 | ISBT Science Series
Hepatitis B virus (HBV) remains the most frequent cause of transfusion‐transmitted viral infection. HBV is highly infectious with minimal 50% chimpanzee infectious dose (CID50) of 10 copies at the pre‐acute phase of infection. However, HBV is not always infectious via transfusion. The infectivity of HBV depends on (1) viral properties such as viral load, phase of infection, genotype and genome mutations, (2) transfusion factors such as blood volume, types of components, concurrent transfusion of anti‐HBs‐positive blood, and (3) recipient factors such as extant anti‐HBs acquired either by natural infection or vaccination, immune‐competence. The risk of HBV infections remaining after HBsAg screening is associated with donations during the preseroconversion window period and of oc...

Methylation of suppressor of cytokine signalling 1 gene promoter is associated with acute‐on‐chronic hepatitis B liver failure
Tue, 22 Jul 2014 00:15:37 +0100 | Journal of Viral Hepatitis
This study was therefore to identify the potential role of SOCS1 and its promoter methylation pattern in ACHBLF patients. Sixty ACHBLF patients, 60 chronic hepatitis B (CHB) patients and 30 healthy controls were investigated in this study. We found that expression of SOCS1 mRNA in CHB and ACHBLF patients was significantly higher than that in healthy controls. The serum level of IL‐6, IFN‐γ and TNF‐α was significantly higher in ACHBLF than CHB. Increased serum level of IL‐6, IFN‐γ and TNF‐α was correlated with total bilirubin, ALT, PTA and MELD scores in ACHBLF. The degree of methylation of the SOCS1 in ACHBLF patients (35.0%, 21/60) was significantly higher than that in CHB patients (16.7%, 10/60). Furthermore, methylated group showed lower level of SOCS1, and higher MELD s...